Net Net Stock Overview

Subscribe

To see hundreds more international net nets, consider subscribing

Overview

ReShape Lifesciences Inc
Healthcare
P/NCAV
0.16x
Ticker
RSLS
Exchange
NASDAQ
Country
United States
Close
0.17 $
Mkt Cap
1.0M $
EV
-3.5M $
NCAV Burn Rate
-159.1%
Current Ratio
2.73
Debt/Equity
0.0
EV/REV
-0.4x
EV/EBIT
0.2x
EV/FCF
0.2x
Dilution
101.9% p.A
Total Net Income
-273.6M $
Cheapness
1.0%
ReShape Lifesciences Inc. is a weight-loss and metabolic health-solutions company. The Company offers an integrated portfolio of products and services that manage and treat obesity and metabolic disease. Its Lap-Band System provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures, such as gastric bypass or sleeve gastrectomy. The investigational Diabetes Bloc-Stim Neuromodulation (DBSN) system utilizes a vagus nerve block and stimulation technology platform for the treatment of type II diabetes and metabolic disorders. The Obalon balloon technology is a non-surgical, swallowable, gas-filled intra-gastric balloon that is designed to provide long-lasting weight loss. Its ReShape Calibration tubes are multifunctional devices compared to reusable bougies and disposable gastric tubes. Its Lap-Band 2.0, like the original Lap-Band System, is designed to provide minimally invasive long-term treatment of severe obesity.

Profitability

positive values --- Average negative values

Margins

--- Average

Valuation

positive values --- Average negative values

Dilution

--- Average